Antibiotic Treatment for Pneumonia Caused by Stenotrophomonas Maltophilia in ICU Patients
Recruiting
Observational Study
Pneumonia, Ventilator-Associated
Stenotrophomonas Maltophilia
Intensive Care Units
Anti-Bacterial Agents
Drug Resistance, Bacterial
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 300 (estimated)
- Sponsor
- Centre Hospitalier de Saint-Denis · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study looks at how different antibiotic treatments affect patients in intensive care who have pneumonia caused by the bacteria Stenotrophomonas maltophilia. It compares using one antibiotic versus two antibiotics, and treatment lengths of 7 days versus 14 days, to see which approach helps patients survive better. The study also examines how resistant the bacteria are to antibiotics and how of…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Adult patients (age ≥ 18 years)
* Hospitalized in Medical Intensive Care Unit between January 1, 2018, and December 31, 2023
* Intubated and mechanically ventilated
* Diagnosed with ventilator-associated pneumonia caused by Stenotrophomonas maltophilia
Exclusion Criteria:
* …
Contacts
No contact information available.